Provision of Cardiac Cath Lab Managed Service

Description

We have 5 cardiac cath labs at Hammersmith which are managed under contract by an external provider until 31st October 2023. We are currently considering options for the future provision of cath lab services beyond this date so intend to engage with the market via formal preliminary market consultation in accordance with Regulations 40 and 41 of the Public Contract Regulations (PCR) 2015 to understand the level of market interest and to gather information from market suppliers with a view to preparing a public procurement exercise, and to also inform prospective bidders of our procurement plans Lot 1: Imperial College Healthcare NHS Trust provides acute and specialist healthcare for a population of nearly two million people in North West London, and more beyond. We have five hospitals: Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and The Western Eye, as well as a growing number of community services. With our academic partner, Imperial College London, we are one of the UK’s seven academic health science centres, working to ensure the rapid translation of research for better patient care and excellence in education. We are also part of Imperial College Health Partners, the academic health science network for North West London, spreading innovation and best practice in healthcare more widely across their region. Imperial College Healthcare NHS Trust are also a partner within the North West London Integrated Care System (ICS).<br/><br/>The cardiology service at Trust, based at Hammersmith Hospital (W12 0HS), is a world-class tertiary referral cardiac centre led by specialists with academic interests and leaders in their field. We use cutting-edge clinical innovations to treat and prevent heart conditions and offer a full range of investigations, treatments and management for cardiac conditions.<br/><br/>Our cardiology service treats the following conditions:<br/>• Ischaemic heart disease<br/>• Arrhythmia and electrophysiology<br/>• Cardiac pacemaker and implantable cardioverter defibrillator (ICD)<br/>• Pulmonary hypertension<br/>• Valvular heart disease<br/>• Structural heart disease<br/>• Cardio-renal disease<br/>• Heart failure<br/>• Hypertension<br/>• Lipid disorders<br/>• Syncope<br/>• Inherited cardiac conditions<br/><br/>We have 5 cardiac cath labs at Hammersmith which are managed under contract by an external provider until 31st October 2023. We are currently considering options for the future provision of cath lab services beyond this date so intend to engage with the market via formal preliminary market consultation in accordance with Regulations 40 and 41 of the Public Contract Regulations (PCR) 2015 to understand the level of market interest and to gather information from market suppliers with a view to preparing a public procurement exercise, and to also inform prospective bidders of our procurement plans. <br/><br/>Suppliers are invited to complete and return a trust questionnaire document which requests feedback on specific elements of the intended procurement process. Please contact lee.matthews2@nhs.nhs and louisa.campbell7@nhs.uk to request these documents via email.<br/><br/>Completion of the questionnaire will in no way obligate your organisation to participate in any follow-up procurement process. Conversely, failing to participate in this process will in no way preclude your organisation from participating in a future related tender. This is an entirely voluntary process. Any information provided as part of this preliminary market consultation will be processed in accordance with applicable confidentiality laws. Additional information: Please contact lee.matthews2@nhs.nhs and louisa.campbell7@nhs.uk to request the questionnaire document.<br/><br/>Participation in this Preliminary Market Consultation exercise is entirely voluntary. Participation or a lack of participation will have no bearing during any future tender exercise.